Seragen Biotherapeutics
Seragen is a fertility-focused biotech venture leveraging regenerative medicine and AI to personalize fertility and gynecology care. Their AI platform, Conceivf, integrates reproductive health datasets to provide insights for conditions like low AMH, high FSH, thin endometrium, and estrogen imbalance. Seragen also develops personalized therapeutic dosages based on autologous plasma growth factors and biomarkers. They offer specialized treatments for recurrent pregnancy loss and unexplained infertility through an immunological evaluation and reporting platform. Seragen's approach is data-driven, research-backed, and emphasizes quality care through a network of ISO-certified and NABH-compliant hospitals, aiming to improve conception certainty and offer innovative solutions for unmet infertility needs.
Seragen Biotherapeutics
Seragen is a fertility-focused biotech venture leveraging regenerative medicine and AI to personalize fertility and gynecology care. Their AI platform, Conceivf, integrates reproductive health datasets to provide insights for conditions like low AMH, high FSH, thin endometrium, and estrogen imbalance. Seragen also develops personalized therapeutic dosages based on autologous plasma growth factors and biomarkers. They offer specialized treatments for recurrent pregnancy loss and unexplained infertility through an immunological evaluation and reporting platform. Seragen's approach is data-driven, research-backed, and emphasizes quality care through a network of ISO-certified and NABH-compliant hospitals, aiming to improve conception certainty and offer innovative solutions for unmet infertility needs.